China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,176 | 18,129 | 12,077 | 17,369 | 15,570 |
| Receivables | 3,005 | 1,719 | 1,315 | 1,345 | 3,333 |
| Inventories | 777 | 828 | 795 | 531 | 1,018 |
| Other current assets | 2,179 | 301 | 15 | 46 | 1,667 |
| TOTAL | $34,510 | $21,297 | $14,233 | $19,521 | $22,452 |
| Non-Current Assets | |||||
| PPE Net | 117 | 179 | 329 | 962 | 1,228 |
| Investments And Advances | 0 | 0 | 8,310 | 8,737 | 9,465 |
| Intangibles | 6 | 12 | 19 | 28 | 39 |
| Other Non-Current Assets | 122 | 177 | 236 | 306 | 363 |
| TOTAL | $245 | $367 | $8,894 | $10,033 | $11,094 |
| Total Assets | $34,755 | $21,664 | $23,127 | $29,554 | $33,546 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 355 | 711 | 2,295 | 3,333 | 2,046 |
| Accounts payable and accrued liabilities | 498 | 1,158 | 2,327 | 6,582 | 10,178 |
| Accrued Expenses | 3,305 | 2,938 | 2,768 | 3,142 | 3,530 |
| Other current liabilities | 121 | 113 | 401 | 278 | 200 |
| TOTAL | $4,349 | $6,012 | $8,902 | $14,497 | $17,122 |
| Non-Current Liabilities | |||||
| Long Term Debt | 644 | 96 | 117 | 118 | N/A |
| Other Non-Current Liabilities | 53 | 115 | 178 | 248 | 0 |
| TOTAL | $698 | $212 | $295 | $366 | $N/A |
| Total Liabilities | $5,047 | $6,224 | $9,197 | $14,863 | $17,122 |
| Shareholders' Equity | |||||
| Common Shares | 64,126 | 44,531 | 39,668 | 914 | 163 |
| Retained earnings | -34,220 | -28,015 | -24,712 | -21,613 | -15,688 |
| Other shareholders' equity | -198 | -1,076 | -1,026 | -198 | 956 |
| TOTAL | $29,707 | $15,440 | $13,931 | $14,691 | $16,425 |
| Total Liabilities And Equity | $34,755 | $21,664 | $23,127 | $29,554 | $33,546 |